Neurotech out of Louvain-la-Neuve, Belgium received regulatory approval to offer its ADNS-300 vagus nerve stimulator implant to patients that showed resistance to anti-epileptic drugs and are not good candidates for brain surgery.
The device is rechargeable and can be turned on/off by the patient using a remote control. It features software that monitors nerve signals and may help predict oncoming seizures.
System components from the product page:
Internal components of the ADNS-300
- Small size and low weight
- Rechargeable battery guaranteeing a recharge session once a month during the first 10 years
- Rechargeable stimulator with extended lifetime up to 15 years
- Contemporary high-speed wireless connectivity between physician and VNS for parameter setting
- Precise current stimulation
- Impedance measurement and data logging
- Controller activation history is recorded
- Nerve action potential monitoring, providing the physician with additional information
- Easy electrode placement by original self-sizing cuff design with improved stability
- Charger for at home recharging once every weeks for the first 10 years, using a simple charging coil fixed on the skin with an adhesive patch, over the implantation site.
- PDA /PC using proprietary software and wireless telemetry enabling communication with the ADNS-300
- Patient controller allowing 3 different stimulation programs with confirmation for the patient
Product page: Neurotech’s ADNS-300 Vagus Nerve Stimulator…